PROCEPT BioRobotics Corporation PRCT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$102.47M-7.2% | -$95.57M-13.0% | -$84.58M-0.5% | -$84.15M+6.7% | -$90.19M+1.3% | ||
| $6.65M+4.1% | $6.39M+4.2% | $6.13M+5.0% | $5.84M+5.8% | $5.53M+5.6% | ||
| $50.57M+6.2% | $47.6M+3.8% | $45.85M+15.0% | $39.87M+11.7% | $35.69M+12.1% | ||
| —— | —— | $1.81M+4.0% | $1.74M+48.7% | $1.17M+39.3% | ||
| —— | —— | —— | —— | $24.33M-32.4% | ||
| $15.81M+4.9% | $15.07M-10.7% | $16.87M-29.8% | $24.02M+9.0% | $22.03M+27.8% | ||
| —— | —— | —— | —— | —— | ||
| $511K-53.6% | $1.1M-58.8% | $2.67M+19.7% | $2.23M+14.1% | $1.96M-39.1% | ||
| —— | —— | —— | $1.9M+122% | $855K-51.7% | ||
| $3.71M+11.8% | $3.32M+19.1% | $2.79M-10.0% | $3.09M-17.4% | $3.75M+0.8% | ||
| —— | -$157K-33.3% | -$117.75K-50.0% | -$78.5K-100% | -$39.25K— | ||
| $3.46M+118% | $1.59M-45.4% | $2.91M+107% | $1.41M-59.9% | $3.51M-24.6% | ||
| -$70.13M-43.2% | -$48.99M+31.1% | -$71.05M+14.6% | -$83.21M+0.8% | -$83.91M+15.4% | ||
| $10.43M+11.5% | $9.36M+7.8% | $8.68M+43.3% | $6.06M+40.9% | $4.3M-2.5% | ||
| -$10.43M-11.5% | -$9.36M-7.8% | -$8.68M-43.3% | -$6.06M-40.9% | -$4.3M+2.5% | ||
| -$1.08M— | $0-100% | $167.75M+4.2% | $160.91M-1.4% | $163.21M-0.8% | ||
| $10.12M-9.6% | $11.19M-93.7% | $177.28M-0.4% | $177.92M-0.5% | $178.84M-0.7% | ||
| -$116K-56.8% | -$74K-124% | -$33K-43.5% | -$23K— | —— | ||
| -$70.57M-49.4% | -$47.22M-148% | $97.52M+10.0% | $88.62M-2.2% | $90.63M+18.5% | ||
| $3.38M-2.4% | $3.46M-2.6% | $3.56M-3.6% | $3.69M-4.2% | $3.85M-3.0% | ||
| $3.46M+118% | $1.59M-45.4% | $2.91M+107% | $1.41M-59.9% | $3.51M-24.6% | ||
| $166K+16.9% | $142K+10.9% | $128K+6.7% | $120K-5.5% | $127K-5.2% | ||
| $2.93M+1.2% | $2.9M-11.6% | $3.28M+24.7% | $2.63M+41.4% | $1.86M+9.0% | ||
| $511K-53.6% | $1.1M-58.8% | $2.67M+19.7% | $2.23M+14.1% | $1.96M-39.1% | ||
| $461K-18.6% | $566K-51.5% | $1.17M-20.5% | $1.47M-32.8% | $2.18M+15.9% | ||
| $540K+6.3% | $508K+6.5% | $477K+7.0% | $446K+7.7% | $414K+8.1% | ||
| —— | —— | $1.81M+4.0% | $1.74M+48.7% | $1.17M+39.3% | ||
| —— | —— | —— | —— | —— | ||
| -$116K-56.8% | -$74K-124% | -$33K-43.5% | -$23K— | —— | ||
| —— | —— | —— | —— | —— | ||
| $3.71M+11.8% | $3.32M+19.1% | $2.79M-10.0% | $3.09M-17.4% | $3.75M+0.8% | ||
| -$80.57M-38.1% | -$58.34M+26.8% | -$79.73M+10.7% | -$89.27M-1.2% | -$88.21M+14.9% | ||
| -$80.57M-38.1% | -$58.34M+26.8% | -$79.73M+10.7% | -$89.27M-1.2% | -$88.21M+14.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does PROCEPT BioRobotics Corporation generate?
- PROCEPT BioRobotics Corporation (PRCT) generated -$70.1M in operating cash flow over the trailing twelve months.
- What is PROCEPT BioRobotics Corporation's free cash flow?
- After $10.4M of capital expenditures, PROCEPT BioRobotics Corporation's free cash flow was -$80.6M over the trailing twelve months, up 8.7% year over year.
- Where does PROCEPT BioRobotics Corporation's cash flow data come from?
- Every line is extracted from PROCEPT BioRobotics Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
